This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1 AV Chobanian (1991) Single risk factor intervention may be inadequate to inhibit atherosclerosis progression when hypertension and hypercholesterolemia coexist. Hypertension 18, 130–131.
3 D Steinberg (1997) Oxidative modification of LDL and atherogenesis. Circulation 95, 1062–1071.
4 H Esterbauer , J Gebicki , H Puhl & G Jurgens (1992) The role of lipid peroxidation and antioxidants in oxidative modifications of LDL. Free Radic Biol Med 13, 341–390.
6 JA Berliner , MC Territo , A Sevanian , (1990) Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 85, 1260–1266.
8 W Palinski , ME Rosenfeld , S Yla-Herttuala , (1989) Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A 86, 1372–1376.
9 W Craig (1995) Autoantibodies against oxidized low density lipoportein: a review of clinical findings and assay methodology. J Clin Lab Anal 9, 70–74.
11 T Lehtimaki , S Lehtinen , T Solakivi , (1999) Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease. Arterioscler Thromb Vasc Biol 19, 23–27.
12 T Inoue , T Uchida , H Kamishirado , (2001) Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease. J Am Coll Cardiol 37, 775–779.
13 T Shoji , Y Nishizawa , M Fukumoto , (2000) Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Atherosclerosis 148, 171–177.
14 S Yla-Herttuala , W Palinski , ME Rosenfeld , (1989) Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 84, 1086–1095.
16 PD Reaven , S Parthasarathy , BJ Grasse , E Miller , D Steinberg & J Witztum (1993) Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects. J Clin Invest 91, 668–676.
17 WQ Gradek , MT Harris , N Yahia , WW Davis , NA Le & WV Brown (2004) Polyunsaturated fatty acids acutely suppress antibodies to malondialdehyde-modified lipoproteins in patients with vascular disease. Am J Cardiol 93, 881–885.
18 NA Le , X Li , S Kyung & WV Brown (2000) Evidence for the in vivo generation of oxidatively modified epitopes in patients with atherosclerotic endothelium. Metabolism 49, 1271–1277.
21 FJ Tinahones , JM Gomez-Zumaquero , G Rojo-Martinez , (2002) Increased levels of anti-oxidized low-density lipoprotein antibodies are associated with reduced levels of cholesterol in the general population. Metabolism 51, 429–431.
22 FJ Tinahones , JM Gomez-Zumaquero , L Garrido-Sanchez , (2005) Influence of age and sex on levels of anti-oxidized LDL antibodies and anti-LDL immune complexes in the general population. J Lipid Res 46, 452–457.
23 E Balada , J Ordi-Ros , L Matas , M Mauri , S Bujan & M Vilardell-Tarres (2002) Atherosclerosis and anti-oxidized low density lipoprotein antibodies in an elderly population. Med Clin (Barc) 119, 161–165.
24 A Festa , HP Kopp , G Schernthaner & EJ Menzel (1998) Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications. Diabetologia 41, 350–356.
25 J Karvonen , M Paivansalo , YA Kesaniemi & S Horkko (2003) Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis. Circulation 108, 2107–2112.
26 S Horkko , DA Bird , E Miller , (1999) Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest 103, 117–128.
27 S Freigang , S Horkko , E Miller , JL Witztum & W Palinski (1998) Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler Thromb Vasc Biol 18, 1972–1982.
28GISSI-Prevenzione Investigators (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354, 447–455.
30 EB Schmidt , SD Kristensen , R De Caterina & DR Illingworth (1993) The effects of n-3 fatty acids on plasma lipids and lipoproteins and the other cardiovascular risk factors in patients with hyperlipidemia. Atherosclerosis 103, 107–121.
31 PH Levine , N Fisher , PB Schneider , (1989) Dietary supplementation with omega-3 fatty acids prolongs platelet survival in hyperlipidemic patients with atherosclerosis. Arch Intern Med 149, 1113–1116.
32 P Singer , M Wirth , I Berger , (1985) Influence of serum lipids, lipoproteins and blood pressure of mackerel and herring diet in patients with type IV and V hyperlipoproteinemia. Atherosclerosis 56, 111–118.
35 JL Witztum & D Steinberg (1991) Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88, 1785–1792.
37 M Suzukawa , T Ishikawa , H Yoshida & H Nakamura (1995) Effect of in vivo supplementation with low-dose vitamin E on susceptibility of low-density lipoprotein and high-density lipoprotein to oxidative modification. J Am Coll Nutr 14, 46–52.
39 MD Mesa , R Buckley , A Marieinibane & R Yaqoob (2004) Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on theoxidizability and thrombogenicity of low-density lipoprotein. Atherosclerosis 175, 333–343.
40 S Nomura , S Kanazawa & S Fukuhara (2003) Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with type 2 diabetes mellitus. J Diabetes Complications 17, 153–159.
41 O Johansen , I Seljeflot , AT Hostmark & H Arnesen (1999) The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 19, 1681–1686.
42 F Thies , EA Miles , G Nebe-von-Caron , (2001) Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids 36, 1183–1193.
43 CM Aguilera , MC Ramirez-Tortosa , MD Mesa , CL Ramirez-Tortosa & A Gil (2002) Sunflower, virgin-olive and fish oils differentially affect the progression of aortic lesions in rabbits with experimental atherosclerosis. Atherosclerosis 162, 335–344.
44 FB Hu , L Bronner , WC Willett , (2002) Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 287, 1815–1821.
46 JW Alexander (1998) Immunonutrition: the role of omega-3 fatty acids. Nutrition 14, 627–633.